Patents by Inventor Cécile Servais

Cécile Servais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8952064
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: February 10, 2015
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Francis Vanderbist, Cécile Servais, Philippe Baudier
  • Publication number: 20130217769
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: December 13, 2012
    Publication date: August 22, 2013
    Applicants: GALEPHAR M/F
    Inventors: Francis Vanderbist, Cécile Servais, Phillippe Baudier
  • Publication number: 20130158119
    Abstract: Pharmaceutical semi-solid composition of Isotretinoin An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: June 18, 2012
    Publication date: June 20, 2013
    Inventors: Francis Vanderbist, Cécile Servais, Philippe Baudier
  • Publication number: 20130096196
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: June 18, 2012
    Publication date: April 18, 2013
    Inventors: Franois Vanderbist, Cécile Servais, Philippe Baudier
  • Patent number: 8367102
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: February 5, 2013
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Francis Vanderbist, Cécile Servais, Phillippe Baudier